Competitive Salary: EMBL: Bioinformatics Community Project Manager Location: Germany (DE)

Notice NOT-ES-21-005 from the NIH Guide for Grants and Contracts

Notice NOT-AI-21-015 from the NIH Guide for Grants and Contracts

Notice NOT-HL-21-001 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-21-083 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages cooperative agreement applications for implementation of investigator-initiated, high-risk clinical trials and mechanistic studies associated with high-risk clinical trials. Mechanistic work in clinical trials may be of great value because it promotes the understanding of human diseases and the development of future therapeutic modalities. Investigators are encouraged to visit the NIAID website for additional information about the research mission and high-priority research areas of the NIAID (https://www.niaid.nih.gov/research/role). Only one clinical trial may be proposed in each NIAID Clinical Trial Implementation Cooperative Agreement (U01) application.

Funding Opportunity PAR-21-082 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to implement investigator-initiated clinical trials related to the research mission of the NIAID. This program provides support for hypothesis-driven, milestone-driven clinical trials. Although clinical trials not considered high-risk may be proposed, this program encourages high-risk clinical studies. High-risk does not imply human subject or patient risk, but rather defines a study that contains one or more of the following unique features: involves non-routine interventions, administration of an unlicensed product, or administration of a licensed product for an unapproved indication. Mechanistic studies are also encouraged and can be proposed under this program.

Funding Opportunity RFA-HS-21-001 from the NIH Guide for Grants and Contracts. This initiative will fund up to 5 projects to use lessons learned from previous AHRQ primary care practice improvement initiatives to implement and test implementation strategies to address urinary incontinence in women, and to integrate it with specialty care. Projects may draw on community-based resources and/or include multilevel implementation strategies aligning improvement strategies between primary care practices and healthcare systems.

Notice NOT-DA-21-026 from the NIH Guide for Grants and Contracts

Competitive salaried position with benefits.: IDEXX: The LCMS group is looking for a broadly trained, creative, and energetic Senior Computational Biologist specializing in big data. Westbrook, Maine (US)

Notice NOT-HD-21-003 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-21-148 from the NIH Guide for Grants and Contracts. The purpose of the NIOSH Support for Conferences and Scientific Meetings (R13) is to support high quality scientific meetings, conferences, and workshops that are relevant to NIOSHs scientific mission and that promote occupational safety and health, NIOSH program priorities, and public health. The conference program is integral to the overall mission of NIOSH. An application should address and advance important areas of research in the field of occupational safety and health of particular interest to NIOSH programs and the National Occupational Research Agenda.

Funding Opportunity PA-21-110 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage pilot and/or feasibility research in the following areas: 1) the development and pilot testing of new or adapted interventions to prevent or delay the initiation of substance use and/or the progression from use to misuse or disorder and 2) pre-trial feasibility and acceptability testing of services and service system research relevant to the prevention of substance use. In addition to the prevention of substance use, misuse and disorder, other outcomes of interest for the research supported through FOA include a reduction in negative sequalae such as deaths related to impaired driving, suicidal behavior (e.g., nonfatal and fatal attempts), and drug- or alcohol-related acquisition or transmission of HIV infection and viral hepatitis among diverse populations and settings.

Funding Opportunity RFA-TR-21-010 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support basket clinical trials of drugs targeting shared molecular etiologies in more than one rare disease. To facilitate clinical trial start up, and leverage existing datasets, preference will be given to applications focusing on diseases that are under study by the Rare Disease Clinical Research Network (RDCRN), and that involve collaborations with RDCRN clinical investigators.

Funding Opportunity RFA-DK-21-001 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement is to promote the development of prognostic, monitoring, and diagnostic biomarkers for diabetic foot ulcers that can be used in clinicaltrials and patient care. This initiative would support early analytical and clinical validation of biomarkers through a phased award to encourage innovative research. The initiative would leverage the resources of the Diabetic Foot Consortium to facilitate the access to well-characterized patients and high-quality human samples. The goal of this initiative is to deliver candidate biomarkers that are ready for definitive analytical and clinical validation studies through the Diabetic Foot Consortium.

Up to £45,000 depending on experience, with benefits and share options: Singular Talent: Molecular/Cellular Biologist with an immunology background? Want to spend your time exploring genomic dark matter for drug targets? Thought so..... Oxford, Oxfordshire (GB)

The University of Wisconsin-Madison fulfills its public mission by creating a welcoming and inclusive community for people from every background - people who as…
From University of Wisconsin–Madison - Tue, 12 Jan 2021 18:57:15 GMT - View all Madison, WI jobs

£32,557 - £35,888 per annum: Animal and Plant Health Agency: APHA scientific activity focuses on protecting UK against the threat of a wide variety of animal diseases. Research... Weybridge, Surrey

Notice NOT-HS-21-007 from the NIH Guide for Grants and Contracts

Notice NOT-RM-21-010 from the NIH Guide for Grants and Contracts

Notice NOT-MH-21-155 from the NIH Guide for Grants and Contracts